Skip to Content Skip to Search

About us

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer

About us

We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. Every day, we help improve the health of millions of people around the world.

Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.

Our values and expectations are at the heart of everything we do - so that together we can deliver extraordinary impact for our patients and consumers and make GSK a brilliant place to work. Our values are Patient focus, Transparency, Respect, Integrity. Our expectations are Courage, Accountability, Development, Teamwork.

We have committed to accelerate our progress on inclusion and diversity and to be a leading company in how we support employee health, wellbeing and personal development.

Here in Australia, our business is strong and sustainable, reporting total revenues of $840 million in 2018. In the same year, our world-class manufacturing facilities in Victoria and New South Wales exported high quality products worth more than $345 million. Across the country, we employ approximately 1500 Australians in areas of expertise from medicines to manufacturing and at all levels, from industry-based learning programs for students through to senior executives.

What we do

We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people.


Immune system T-cells attacking cancer cells


Herpes zoster virus of Shingles

Consumer Healthcare

Novamin, a key technology in Sensodyne Repair and Protect.

How we do it

Everyone at GSK is focused on our 3 long-term priorities – Innovation, Performance, Trust, all powered by our performance-focused culture.


Innovation is at the heart of delivering GSK’s purpose, by using our science to develop better medicines, vaccines, and consumer healthcare products. 

We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.


  • £4.3bn

    adjusted R&D investment in 2019

  • 40

    new medicines in development at Q3 2020

  • 18

    new vaccines in development at Q3 2020


We deliver growth by investing effectively in our business, developing our people and executing competitively.


  • £33.8bn

    turnover in 2019

  • £9bn

    adjusted operating profit in 2019

  • £5.1bn

    free cash flow in 2019

  • £4bn

    dividends paid in 2019


We are a responsible company – using our science and technology to address health needs, we are focused on making our products affordable and available and being a modern employer.


  • 78%

    employee engagement score on our latest employee survey

  • £263m

    donated in 2019 to community health programs

  • 1st

    in Access to Medicines Index since the assessment began in 2008